Urine Dipstick Analysis Part II: LE, Nitrite, Protein, Glucose, Clinitest

Leukocyte Esterase (LE)

• Definition and purpose

  • LE is an enzyme found in white blood cells (WBCs).
  • Detects the presence of WBCs in urine (leukocyturia).
  • A positive LE often indicates infection or inflammation in the urinary tract.
  • Pyuria refers to pus in the urine and correlates with LE and bacteria; can occur with infections such as Trichomonas or Chlamydia.

• Normal values and interpretation

  • Normal LE is negative.
  • Typical WBC count in urine that can be considered normal: about 0–2, or 2–5 WBCs per high‑power field (HPF).
  • A positive LE is usually accompanied by bacteria in the urine (bacteriuria).
  • Sensitivity: LE tends to become positive around
    $10–20\;\text{WBCs/µL}$
    (i.e., near the higher end of microscopic counts); if you have only ~2 WBCs/HPF, LE may still be negative.

• Mechanism (what you should know about the pad chemistry)

  • The dipstick pad contains an ester substrate and a diazonium salt.
  • Leukocyte esterase cleaves the ester to form an aromatic compound.
  • The aromatic compound then reacts with the diazonium salt, producing a color change (beige to violet).
  • You don’t need to memorize exact colors, but the basic principle is enzymatic cleavage leading to a colored product on the pad.

• Correlations and clinical context

  • If LE is positive, expect possible bacteria in the urine; infection/inflammation is common.
  • There is a correlation with pyuria (pus in urine) and leukocyturia.
  • Presence of lymphocytes (a non‑granulocytic cell type) in urine may yield a false negative LE because LE is present predominantly in granulocytic WBCs (neutrophils).

• Anatomical/physiological notes

  • LE is present in granulocytic WBCs, not in lymphocytes; this matters when correlating dipstick and microscopic results.

• Interferences and limitations

  • False positives:
  • Vaginal discharge can contaminate the sample.
  • Drugs or foods that color urine red can cause a false positive color change.
  • False negatives:
  • Very high protein, glucose, or very high specific gravity can mask LE.
  • Certain drugs (e.g., gentamicin, cephalosporins) or oxidizing agents can reduce dipstick reactivity, causing a false negative.
  • Microscopy correlation is essential: LE positivity with no WBCs on microscopy could prompt re‑evaluation.

• Practical clinical emphasis

  • Use LE in conjunction with microscopic exam and nitrite to assess UTIs and related conditions.

  Nitrite

• Purpose and what it detects

  • Nitrite on the dipstick looks for bacteria in urine that can reduce nitrate to nitrite.
  • This test helps identify UTIs caused by nitrate‑reducing bacteria.

• Bacteria that do and do not reduce nitrate

  • Nitrate reducers (most common): Gram‑negative rods such as Escherichia coli.
  • Not a nitrate reducer: Staphylococcus aureus (Gram‑positive cocci) can cause a UTI but will not yield a positive nitrite result.

• Mechanism

  • Nitrate (NO3−) in urine is reduced to nitrite (NO2−) by certain bacteria.
  • The dipstick detects nitrite via a reaction where nitrite reacts with the pad chemistry to produce a color change (diazonium salt formation involving an aromatic amine).

• Interpretive notes

  • Ideal samples: first morning/overnight specimen, allowing at least ~4 hours for bacteria to reduce nitrate to nitrite.
  • Why timing matters:
  • If urine is held too long (e.g., ~12 hours), nitrite production may proceed to nitrate depletion and bacteria may stop producing nitrite, potentially yielding a false negative.
  • False positives:
  • Red or heavily colored urine can interfere with interpretation and yield a false positive.
  • Improper storage/handling can artifactually produce nitrite.
  • False negatives:
  • Ascorbic acid (vitamin C) can suppress nitrite formation.

• Clinical notes

  • A positive nitrite strongly suggests bacteria in urine but is not definitive; sensitivity varies with organism type and urine composition.
  • A negative nitrite does not exclude UTI, especially with non‑nitrate‑reducing bacteria or low bacterial counts.

  Protein

• Clinical significance

  • Protein in urine (proteinuria) can indicate kidney disease; small amounts of low‑molecular‑weight proteins can be normal.
  • Large proteins in urine suggest renal pathology.
  • The dipstick primarily detects albumin.

• Types of proteinuria (four categories)

  • Prerenal (overflow) proteinuria: due to increased serum proteins spilling into urine (e.g., multiple myeloma, other systemic protein abnormalities).
  • Glomerular proteinuria: due to glomerular damage (e.g., nephrotic syndrome); associated with hypoalbuminemia in blood.
  • Tubular proteinuria: due to tubular reabsorptive dysfunction; may accompany Fanconi/Impairment syndromes with amino acids, glucose, phosphate losses.
  • Postrenal proteinuria: due to inflammation or injury downstream of the kidneys (ureters, bladder, urinary tract).

• Mechanism (indicator chemistry)

  • Protein reagent strip uses the protein error of indicators: proteins modulate the dye indicator, releasing H+ and decreasing pH locally.
  • Resulting color change: from blue to green; intensity correlates with the amount of protein.

• Interferences and limitations

  • Primary sensitivity is to albumin; other proteins (globulins, Bence Jones proteins, hemoglobin) may be detected but with less sensitivity.
  • Very alkaline urine (pH > 9.0) can cause false positives.
  • Very dilute urine can cause false negatives because analyte concentration is low; pay attention to specific gravity.

• Confirmatory testing

  • SSA (sulfosalicylic acid) test historically used as a confirmatory test for protein in urine; not as commonly performed now, but it can confirm proteinuria.
  • SSA results range from negative to 4+ with increasing turbidity/precipitate.
  • Interference profile for SSA is similar to dipstick (albumin‑predominant, but other proteins can interfere).

• Microalbumin (early detection)

  • Microalbumin testing detects low levels of albumin that may indicate early kidney damage, particularly in:
  • Diabetes mellitus
  • Hypertension
  • Peripheral vascular disease
  • Rationale: early renal damage may occur before overt proteinuria develops; enables early intervention.
  • Testing approaches
  • Use dedicated microalbumin strips or tests that include creatinine to form an albumin/creatinine ratio (ACR).
  • ACR accounts for urine concentration/dilution and helps interpret results in dilute or concentrated urine.

• Practical notes

  • Albumin is the main protein detected on dipstick; other proteins can cause positive results but albumin is the most common clinical target.

  Glucose

• Clinical significance

  • Glucosuria suggests hyperglycemia and/or renal threshold exceedance, but can also occur with other conditions or states.
  • Threshold for glucose spilling into urine is approximately ext{plasma glucose}
    ightarrow ext{urine filtration exceeds reabsorption capacity at } oxed{160 ext{–}180\ \text{mg/dL}}
  • Other etiologies: hormonal disorders, liver disease, pancreatic disease, drugs, CNS damage.

• Glucose vs other sugars in urine

  • Other sugars may appear in urine (galactose, fructose, lactose, maltose, pentose), but the glucose dipstick is designed to specifically detect glucose.
  • Galactose in urine is particularly clinically significant because of galactosemia.

• Non‑glucosuria despite hyperglycemia

  • Hyperglycemia without glucosuria can occur when glomerular filtration rate is reduced (decreased GFR) and filtering capacity is impaired, limiting glucose reaching the filtrate.

• Mechanism (glucose dipstick chemistry)

  • Double sequential enzyme reaction:
  • Glucose oxidase reaction: $\text{Glucose} + \text{O}<em>{2} \xrightarrow{\text{glucose oxidase}} \text{gluconic acid} + \text{H}</em>{2}\text{O}_{2}$
  • Peroxidase reaction: $\text{H}<em>{2}\text{O}</em>{2} + \text{chromogen} \rightarrow \text{oxidized chromogen} + \text{H}_{2}\text{O}$
  • The oxidized chromogen yields a color change on the pad.

• Interferences and limitations

  • False negatives:
  • Ascorbic acid (vitamin C) lowers color development.
  • Improper storage of strips or sample handling.
  • Conditions that lower bacterial consumption or reduce oxidative reactions can contribute to false negatives.
  • High specific gravity, low temperature, or high ketones can decrease test signal.
  • False positives:
  • Strong oxidizing agents or peroxide contaminants can yield false positives.
  • Other factors:
  • Bacteria in urine can metabolize glucose, lowering its concentration and causing a false negative.

• Related tests and concepts

  • Clinitest (copper reduction test) detects reducing substances (not just glucose).
  • Clinically useful to screen for galactose (reducing substances) in addition to glucose.

  Clinitest (Reducing Substances)

• Purpose and scope

  • A qualitative test for detecting reducing substances in urine, primarily used to screen for galactose (galactosemia) in children under two years.
  • Not specific to one analyte; it detects any reducing substance.

• Principle

  • Reducing substances (e.g., galactose, glucose) reduce cupric sulfate (CuSO4) to cuprous oxide (Cu2O).
  • Color change on the tablet/solution from blue‑green to orange‑rust indicates a positive result.

• Procedure (typical)

  • In a tube: add 2–5 drops of urine, then 10 drops of water, then the Clinitest tablet, and mix.
  • Allow ~15 seconds; the reaction generates heat, so the tube may warm.
  • Compare to a reference chart (negative: blue; positive: progressively orange/rust color).

• Interpretation and clinical reasoning

  • If both dipstick glucose and Clinitest are positive, glucose is a likely contributor.
  • If Clinitest is positive and the glucose dipstick is negative, a non‑glucose reducing substance is present (e.g., galactose).
  • If both tests are negative, there are no detectable reducing substances in the sample.
  • If glucose dipstick is positive but Clinitest is negative, this could be due to low glucose concentration that Clinitest did not detect (or a contaminant causing interference on the dipstick).

• Interferences and limitations

  • Not specific for a single analyte; any reducing substance can produce a positive result.
  • False positives: any reducing substance, including glucose, galactose, or other reducing sugars.
  • False negatives: ascorbic acid and radiographic (contrast) media can suppress the reaction.

• Practical clinical connections

  • If the glucose dipstick is negative but Clinitest is positive, look for non‑glucose reducing substances (e.g., galactose), prompting consideration of galactosemia or other metabolic issues.
  • If both tests are positive for glucose, it supports true glucosuria due to hyperglycemia or renal threshold exceedance.

  Integrative notes and practical tips

• Specimen considerations

  • For culture and bacteriuria assessment, the first morning specimen is preferred because bacteria have had at least ~4 hours to proliferate and interact with the nitrate and LE tests.

• Correlation with microscopic exam

  • Always correlate dipstick results with microscopic evaluation of urine sediment (WBCs, bacteria, cells, casts) to avoid misinterpretation from interfering factors (lymphocytes, proteinuria, concentrated urine, drug effects).

• Real‑world relevance

  • LE and nitrite together increase the likelihood of detecting bacterial UTIs, while glucose and Clinitest help differentiate between glucose‑related glucosuria and other reducing substances (e.g., galactose in galactosemia).
  • Microalbumin testing enables early detection of kidney involvement in chronic diseases (diabetes, hypertension), guiding early interventions.

• Summary of key thresholds and signals

  • LE: positive with leukocyturia; LE sensitivity ~ $10–20\ \text{WBCs/µL}$; normal WBCs per HPF: 0–2 or 2–5.
  • Nitrite: positive suggests nitrate‑reducing bacteria; not all bacteria produce nitrite; negative does not rule out UTI.
  • Protein: albumin is primary target; proteinuria categories include prerenal, glomerular, tubular, postrenal; SSA can confirm; microalbumin detects early kidney disease.
  • Glucose: glucosuria at plasma glucose around $160\text{–}180\ \text{mg/dL}$; other sugars may appear; glucose dipstick uses a two‑step enzymatic reaction.
  • Clinitest: detects reducing substances including galactose; use in pediatric screening; interpret with dipstick glucose results to distinguish glucose vs non‑glucose reducers.

  Ethical, philosophical, or practical implications

• Early detection of kidney disease and metabolic disorders (microalbumin, galactosemia screening) has important implications for long‑term health outcomes and preventive care.

• The reliance on qualitative colorimetric tests requires careful interpretation to avoid misdiagnosis, especially given potential interferences (drug effects, sample handling, sample contamination).

• Clinicians must integrate dipstick findings with patient history, symptoms, and confirmatory tests (cultures, SSA, microalbumin ratio) to guide appropriate therapy.